 | • レポートコード：MRC2012A9358 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ウイルス様粒子の世界市場を広く調査・分析し、今後の市場展望をまとめております。ウイルス様粒子の種類別市場規模（アデノ随伴ウイルス、HIV、B型肝炎ウイルス、C型肝炎ウイルス、その他）、用途別市場規模（ワクチン、マイコウイルス、ウイルス研究、治療薬および造影剤、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：GlaxoSmithKline、Agilvax、Takeda、Merck、TechnoVax、Novavax、Serum Institute of India、MedImmune、Medicago、Allergy Therapeutics、Xiamen Innovax Biotech、GeoVax Labs、CPL Biologicals、Cytos Biotechnology、ANGANY Genetics、 ・地域別グローバル市場分析 2015年-2020年 ・ウイルス様粒子の北米市場（アメリカ、カナダ、メキシコ） ・ウイルス様粒子のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ウイルス様粒子のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ウイルス様粒子の南米市場（ブラジル、アルゼンチン） ・ウイルス様粒子の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：アデノ随伴ウイルス、HIV、B型肝炎ウイルス、C型肝炎ウイルス、その他 ・用途別分析：ワクチン、マイコウイルス、ウイルス研究、治療薬および造影剤、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Virus Like Particles market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Virus Like Particles market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Virus Like Particles market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Virus Like Particles market has been segmented into
Adeno-Associated Virus
HIV
Hepatitis B Virus
Hepatitis C Virus
Other
By Application, Virus Like Particles has been segmented into:
Vaccines
Mycoviruses
Virus Research
Therapeutic and Imaging Agents
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Virus Like Particles market presented in the report. This section sheds light on the sales growth of different regional and country-level Virus Like Particles markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Virus Like Particles market.
The report offers in-depth assessment of the growth and other aspects of the Virus Like Particles market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Virus Like Particles Market Share Analysis
Virus Like Particles competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Virus Like Particles sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Virus Like Particles sales, revenue and market share for each player covered in this report.
The major players covered in Virus Like Particles are:
GlaxoSmithKline
Agilvax
Takeda
Merck
TechnoVax
Novavax
Serum Institute of India
MedImmune
Medicago
Allergy Therapeutics
Xiamen Innovax Biotech
GeoVax Labs
CPL Biologicals
Cytos Biotechnology
ANGANY Genetics
Among other players domestic and global, Virus Like Particles market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Virus Like Particles product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Virus Like Particles, with price, sales, revenue and global market share of Virus Like Particles in 2018 and 2019.
Chapter 3, the Virus Like Particles competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Virus Like Particles breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Virus Like Particles market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Virus Like Particles sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Virus Like Particles Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Virus Like Particles Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Adeno-Associated Virus
1.2.3 HIV
1.2.4 Hepatitis B Virus
1.2.5 Hepatitis C Virus
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Virus Like Particles Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Vaccines
1.3.3 Mycoviruses
1.3.4 Virus Research
1.3.5 Therapeutic and Imaging Agents
1.3.6 Other
1.4 Overview of Global Virus Like Particles Market
1.4.1 Global Virus Like Particles Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GlaxoSmithKline SWOT Analysis
2.1.4 GlaxoSmithKline Product and Services
2.1.5 GlaxoSmithKline Virus Like Particles Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Agilvax
2.2.1 Agilvax Details
2.2.2 Agilvax Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Agilvax SWOT Analysis
2.2.4 Agilvax Product and Services
2.2.5 Agilvax Virus Like Particles Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Takeda
2.3.1 Takeda Details
2.3.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Takeda SWOT Analysis
2.3.4 Takeda Product and Services
2.3.5 Takeda Virus Like Particles Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck SWOT Analysis
2.4.4 Merck Product and Services
2.4.5 Merck Virus Like Particles Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 TechnoVax
2.5.1 TechnoVax Details
2.5.2 TechnoVax Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 TechnoVax SWOT Analysis
2.5.4 TechnoVax Product and Services
2.5.5 TechnoVax Virus Like Particles Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novavax
2.6.1 Novavax Details
2.6.2 Novavax Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novavax SWOT Analysis
2.6.4 Novavax Product and Services
2.6.5 Novavax Virus Like Particles Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Serum Institute of India
2.7.1 Serum Institute of India Details
2.7.2 Serum Institute of India Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Serum Institute of India SWOT Analysis
2.7.4 Serum Institute of India Product and Services
2.7.5 Serum Institute of India Virus Like Particles Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 MedImmune
2.8.1 MedImmune Details
2.8.2 MedImmune Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 MedImmune SWOT Analysis
2.8.4 MedImmune Product and Services
2.8.5 MedImmune Virus Like Particles Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Medicago
2.9.1 Medicago Details
2.9.2 Medicago Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Medicago SWOT Analysis
2.9.4 Medicago Product and Services
2.9.5 Medicago Virus Like Particles Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Allergy Therapeutics
2.10.1 Allergy Therapeutics Details
2.10.2 Allergy Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Allergy Therapeutics SWOT Analysis
2.10.4 Allergy Therapeutics Product and Services
2.10.5 Allergy Therapeutics Virus Like Particles Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Xiamen Innovax Biotech
2.11.1 Xiamen Innovax Biotech Details
2.11.2 Xiamen Innovax Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Xiamen Innovax Biotech SWOT Analysis
2.11.4 Xiamen Innovax Biotech Product and Services
2.11.5 Xiamen Innovax Biotech Virus Like Particles Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 GeoVax Labs
2.12.1 GeoVax Labs Details
2.12.2 GeoVax Labs Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 GeoVax Labs SWOT Analysis
2.12.4 GeoVax Labs Product and Services
2.12.5 GeoVax Labs Virus Like Particles Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 CPL Biologicals
2.13.1 CPL Biologicals Details
2.13.2 CPL Biologicals Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 CPL Biologicals SWOT Analysis
2.13.4 CPL Biologicals Product and Services
2.13.5 CPL Biologicals Virus Like Particles Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Cytos Biotechnology
2.14.1 Cytos Biotechnology Details
2.14.2 Cytos Biotechnology Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Cytos Biotechnology SWOT Analysis
2.14.4 Cytos Biotechnology Product and Services
2.14.5 Cytos Biotechnology Virus Like Particles Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 ANGANY Genetics
2.15.1 ANGANY Genetics Details
2.15.2 ANGANY Genetics Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 ANGANY Genetics SWOT Analysis
2.15.4 ANGANY Genetics Product and Services
2.15.5 ANGANY Genetics Virus Like Particles Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Virus Like Particles Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Virus Like Particles Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Virus Like Particles Manufacturer Market Share in 2019
3.3.2 Top 6 Virus Like Particles Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Virus Like Particles Sales, Revenue and Market Share by Regions
4.1.1 Global Virus Like Particles Sales and Market Share by Regions (2015-2020)
4.1.2 Global Virus Like Particles Revenue and Market Share by Regions (2015-2020)
4.2 North America Virus Like Particles Sales and Growth Rate (2015-2020)
4.3 Europe Virus Like Particles Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Virus Like Particles Sales and Growth Rate (2015-2020)
4.5 South America Virus Like Particles Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Virus Like Particles Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Virus Like Particles Sales, Revenue and Market Share by Country
5.1.1 North America Virus Like Particles Sales and Market Share by Country (2015-2020)
5.1.2 North America Virus Like Particles Revenue and Market Share by Country (2015-2020)
5.2 United States Virus Like Particles Sales and Growth Rate (2015-2020)
5.3 Canada Virus Like Particles Sales and Growth Rate (2015-2020)
5.4 Mexico Virus Like Particles Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Virus Like Particles Sales, Revenue and Market Share by Country
6.1.1 Europe Virus Like Particles Sales and Market Share by Country (2015-2020)
6.1.2 Europe Virus Like Particles Revenue and Market Share by Country (2015-2020)
6.2 Germany Virus Like Particles Sales and Growth Rate (2015-2020)
6.3 UK Virus Like Particles Sales and Growth Rate (2015-2020)
6.4 France Virus Like Particles Sales and Growth Rate (2015-2020)
6.5 Russia Virus Like Particles Sales and Growth Rate (2015-2020)
6.6 Italy Virus Like Particles Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Virus Like Particles Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Virus Like Particles Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Virus Like Particles Revenue and Market Share by Regions (2015-2020)
7.2 China Virus Like Particles Sales and Growth Rate (2015-2020)
7.3 Japan Virus Like Particles Sales and Growth Rate (2015-2020)
7.4 Korea Virus Like Particles Sales and Growth Rate (2015-2020)
7.5 India Virus Like Particles Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Virus Like Particles Sales and Growth Rate (2015-2020)
7.7 Australia Virus Like Particles Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Virus Like Particles Sales, Revenue and Market Share by Country
8.1.1 South America Virus Like Particles Sales and Market Share by Country (2015-2020)
8.1.2 South America Virus Like Particles Revenue and Market Share by Country (2015-2020)
8.2 Brazil Virus Like Particles Sales and Growth Rate (2015-2020)
8.3 Argentina Virus Like Particles Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Virus Like Particles Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Virus Like Particles Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Virus Like Particles Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Virus Like Particles Sales and Growth Rate (2015-2020)
9.3 Turkey Virus Like Particles Sales and Growth Rate (2015-2020)
9.4 Egypt Virus Like Particles Sales and Growth Rate (2015-2020)
9.5 South Africa Virus Like Particles Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Virus Like Particles Sales and Market Share by Type (2015-2020)
10.2 Global Virus Like Particles Revenue and Market Share by Type (2015-2020)
10.3 Global Virus Like Particles Price by Type (2015-2020)
11 Global Virus Like Particles Market Segment by Application
11.1 Global Virus Like Particles Sales Market Share by Application (2015-2020)
11.2 Global Virus Like Particles Revenue Market Share by Application (2015-2020)
11.3 Global Virus Like Particles Price by Application (2015-2020)
12 Market Forecast
12.1 Global Virus Like Particles Sales, Revenue and Growth Rate (2021-2025)
12.2 Virus Like Particles Market Forecast by Regions (2021-2025)
12.2.1 North America Virus Like Particles Market Forecast (2021-2025)
12.2.2 Europe Virus Like Particles Market Forecast (2021-2025)
12.2.3 Asia-Pacific Virus Like Particles Market Forecast (2021-2025)
12.2.4 South America Virus Like Particles Market Forecast (2021-2025)
12.2.5 Middle East & Africa Virus Like Particles Market Forecast (2021-2025)
12.3 Virus Like Particles Market Forecast by Type (2021-2025)
12.3.1 Global Virus Like Particles Sales Forecast by Type (2021-2025)
12.3.2 Global Virus Like Particles Market Share Forecast by Type (2021-2025)
12.4 Virus Like Particles Market Forecast by Application (2021-2025)
12.4.1 Global Virus Like Particles Sales Forecast by Application (2021-2025)
12.4.2 Global Virus Like Particles Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Virus Like Particles Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Virus Like Particles by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Virus Like Particles Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 8. GlaxoSmithKline Virus Like Particles Major Business
Table 9. GlaxoSmithKline Virus Like Particles Total Revenue (USD Million) (2017-2018)
Table 10. GlaxoSmithKline SWOT Analysis
Table 11. GlaxoSmithKline Virus Like Particles Product and Services
Table 12. GlaxoSmithKline Virus Like Particles Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Agilvax Basic Information, Manufacturing Base and Competitors
Table 14. Agilvax Virus Like Particles Major Business
Table 15. Agilvax Virus Like Particles Total Revenue (USD Million) (2017-2018)
Table 16. Agilvax SWOT Analysis
Table 17. Agilvax Virus Like Particles Product and Services
Table 18. Agilvax Virus Like Particles Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Takeda Basic Information, Manufacturing Base and Competitors
Table 20. Takeda Virus Like Particles Major Business
Table 21. Takeda Virus Like Particles Total Revenue (USD Million) (2017-2018)
Table 22. Takeda SWOT Analysis
Table 23. Takeda Virus Like Particles Product and Services
Table 24. Takeda Virus Like Particles Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Merck Basic Information, Manufacturing Base and Competitors
Table 26. Merck Virus Like Particles Major Business
Table 27. Merck Virus Like Particles Total Revenue (USD Million) (2017-2018)
Table 28. Merck SWOT Analysis
Table 29. Merck Virus Like Particles Product and Services
Table 30. Merck Virus Like Particles Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. TechnoVax Basic Information, Manufacturing Base and Competitors
Table 32. TechnoVax Virus Like Particles Major Business
Table 33. TechnoVax Virus Like Particles Total Revenue (USD Million) (2017-2018)
Table 34. TechnoVax SWOT Analysis
Table 35. TechnoVax Virus Like Particles Product and Services
Table 36. TechnoVax Virus Like Particles Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Novavax Basic Information, Manufacturing Base and Competitors
Table 38. Novavax Virus Like Particles Major Business
Table 39. Novavax Virus Like Particles Total Revenue (USD Million) (2017-2018)
Table 40. Novavax SWOT Analysis
Table 41. Novavax Virus Like Particles Product and Services
Table 42. Novavax Virus Like Particles Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 44. Serum Institute of India Virus Like Particles Major Business
Table 45. Serum Institute of India Virus Like Particles Total Revenue (USD Million) (2017-2018)
Table 46. Serum Institute of India SWOT Analysis
Table 47. Serum Institute of India Virus Like Particles Product and Services
Table 48. Serum Institute of India Virus Like Particles Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. MedImmune Basic Information, Manufacturing Base and Competitors
Table 50. MedImmune Virus Like Particles Major Business
Table 51. MedImmune Virus Like Particles Total Revenue (USD Million) (2017-2018)
Table 52. MedImmune SWOT Analysis
Table 53. MedImmune Virus Like Particles Product and Services
Table 54. MedImmune Virus Like Particles Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Medicago Basic Information, Manufacturing Base and Competitors
Table 56. Medicago Virus Like Particles Major Business
Table 57. Medicago Virus Like Particles Total Revenue (USD Million) (2017-2018)
Table 58. Medicago SWOT Analysis
Table 59. Medicago Virus Like Particles Product and Services
Table 60. Medicago Virus Like Particles Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Allergy Therapeutics Basic Information, Manufacturing Base and Competitors
Table 62. Allergy Therapeutics Virus Like Particles Major Business
Table 63. Allergy Therapeutics Virus Like Particles Total Revenue (USD Million) (2017-2018)
Table 64. Allergy Therapeutics SWOT Analysis
Table 65. Allergy Therapeutics Virus Like Particles Product and Services
Table 66. Allergy Therapeutics Virus Like Particles Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Xiamen Innovax Biotech Basic Information, Manufacturing Base and Competitors
Table 68. Xiamen Innovax Biotech Virus Like Particles Major Business
Table 69. Xiamen Innovax Biotech Virus Like Particles Total Revenue (USD Million) (2017-2018)
Table 70. Xiamen Innovax Biotech SWOT Analysis
Table 71. Xiamen Innovax Biotech Virus Like Particles Product and Services
Table 72. Xiamen Innovax Biotech Virus Like Particles Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. GeoVax Labs Basic Information, Manufacturing Base and Competitors
Table 74. GeoVax Labs Virus Like Particles Major Business
Table 75. GeoVax Labs Virus Like Particles Total Revenue (USD Million) (2017-2018)
Table 76. GeoVax Labs SWOT Analysis
Table 77. GeoVax Labs Virus Like Particles Product and Services
Table 78. GeoVax Labs Virus Like Particles Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. CPL Biologicals Basic Information, Manufacturing Base and Competitors
Table 80. CPL Biologicals Virus Like Particles Major Business
Table 81. CPL Biologicals Virus Like Particles Total Revenue (USD Million) (2017-2018)
Table 82. CPL Biologicals SWOT Analysis
Table 83. CPL Biologicals Virus Like Particles Product and Services
Table 84. CPL Biologicals Virus Like Particles Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Cytos Biotechnology Basic Information, Manufacturing Base and Competitors
Table 86. Cytos Biotechnology Virus Like Particles Major Business
Table 87. Cytos Biotechnology Virus Like Particles Total Revenue (USD Million) (2017-2018)
Table 88. Cytos Biotechnology SWOT Analysis
Table 89. Cytos Biotechnology Virus Like Particles Product and Services
Table 90. Cytos Biotechnology Virus Like Particles Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. ANGANY Genetics Basic Information, Manufacturing Base and Competitors
Table 92. ANGANY Genetics Virus Like Particles Major Business
Table 93. ANGANY Genetics Virus Like Particles Total Revenue (USD Million) (2017-2018)
Table 94. ANGANY Genetics SWOT Analysis
Table 95. ANGANY Genetics Virus Like Particles Product and Services
Table 96. ANGANY Genetics Virus Like Particles Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Global Virus Like Particles Sales by Manufacturer (2018-2019) (K Pcs)
Table 98. Global Virus Like Particles Revenue by Manufacturer (2018-2019) (USD Million)
Table 99. Global Virus Like Particles Sales by Regions (2015-2020) (K Pcs)
Table 100. Global Virus Like Particles Sales Market Share by Regions (2015-2020)
Table 101. Global Virus Like Particles Revenue by Regions (2015-2020) (USD Million)
Table 102. North America Virus Like Particles Sales by Countries (2015-2020) (K Pcs)
Table 103. North America Virus Like Particles Sales Market Share by Countries (2015-2020)
Table 104. North America Virus Like Particles Revenue by Countries (2015-2020) (USD Million)
Table 105. North America Virus Like Particles Revenue Market Share by Countries (2015-2020)
Table 106. Europe Virus Like Particles Sales by Countries (2015-2020) (K Pcs)
Table 107. Europe Virus Like Particles Sales Market Share by Countries (2015-2020)
Table 108. Europe Virus Like Particles Revenue by Countries (2015-2020) (USD Million)
Table 109. Asia-Pacific Virus Like Particles Sales by Regions (2015-2020) (K Pcs)
Table 110. Asia-Pacific Virus Like Particles Sales Market Share by Regions (2015-2020)
Table 111. Asia-Pacific Virus Like Particles Revenue by Regions (2015-2020) (USD Million)
Table 112. South America Virus Like Particles Sales by Countries (2015-2020) (K Pcs)
Table 113. South America Virus Like Particles Sales Market Share by Countries (2015-2020)
Table 114. South America Virus Like Particles Revenue by Countries (2015-2020) (USD Million)
Table 115. South America Virus Like Particles Revenue Market Share by Countries (2015-2020)
Table 116. Middle East & Africa Virus Like Particles Sales by Countries (2015-2020) (K Pcs)
Table 117. Middle East & Africa Virus Like Particles Sales Market Share by Countries (2015-2020)
Table 118. Middle East & Africa Virus Like Particles Revenue by Countries (2015-2020) (USD Million)
Table 119. Middle East & Africa Virus Like Particles Revenue Market Share by Countries (2015-2020)
Table 120. Global Virus Like Particles Sales by Type (2015-2020) (K Pcs)
Table 121. Global Virus Like Particles Sales Share by Type (2015-2020)
Table 122. Global Virus Like Particles Revenue by Type (2015-2020) (USD Million)
Table 123. Global Virus Like Particles Revenue Share by Type (2015-2020)
Table 124. Global Virus Like Particles Sales by Application (2015-2020) (K Pcs)
Table 125. Global Virus Like Particles Sales Share by Application (2015-2020)
Table 126. Global Virus Like Particles Sales Forecast by Regions (2021-2025) (K Pcs)
Table 127. Global Virus Like Particles Market Share Forecast by Regions (2021-2025)
Table 128. Global Virus Like Particles Sales Forecast by Type (2021-2025) (K Pcs)
Table 129. Global Virus Like Particles Market Share Forecast by Type (2021-2025)
Table 130. Global Virus Like Particles Sales Forecast by Application (2021-2025)
Table 131. Global Virus Like Particles Market Share Forecast by Application (2021-2025)
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Virus Like Particles Picture
Figure 2. Global Sales Market Share of Virus Like Particles by Type in 2019
Figure 3. Adeno-Associated Virus Picture
Figure 4. HIV Picture
Figure 5. Hepatitis B Virus Picture
Figure 6. Hepatitis C Virus Picture
Figure 7. Other Picture
Figure 8. Virus Like Particles Sales Market Share by Application in 2018
Figure 9. Vaccines Picture
Figure 10. Mycoviruses Picture
Figure 11. Virus Research Picture
Figure 12. Therapeutic and Imaging Agents Picture
Figure 13. Other Picture
Figure 14. Global Virus Like Particles Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Virus Like Particles Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Virus Like Particles Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Virus Like Particles Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Virus Like Particles Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Virus Like Particles Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Virus Like Particles Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Virus Like Particles Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Virus Like Particles Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Virus Like Particles Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Virus Like Particles Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Virus Like Particles Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Virus Like Particles Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Virus Like Particles Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Virus Like Particles Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Virus Like Particles Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Virus Like Particles Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Virus Like Particles Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Virus Like Particles Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Virus Like Particles Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Virus Like Particles Sales Market Share by Manufacturer in 2019
Figure 35. Global Virus Like Particles Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Virus Like Particles Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Virus Like Particles Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Virus Like Particles Sales and Growth Rate (2015-2020) (K Pcs)
Figure 40. Global Virus Like Particles Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Virus Like Particles Revenue Market Share by Regions (2015-2020)
Figure 42. Global Virus Like Particles Revenue Market Share by Regions in 2018
Figure 43. North America Virus Like Particles Sales and Growth Rate (2015-2020)
Figure 44. Europe Virus Like Particles Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Virus Like Particles Sales and Growth Rate (2015-2020)
Figure 46. South America Virus Like Particles Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Virus Like Particles Sales and Growth Rate (2015-2020)
Figure 48. North America Virus Like Particles Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Virus Like Particles Sales Market Share by Countries (2015-2020)
Figure 50. North America Virus Like Particles Sales Market Share by Countries in 2018
Figure 51. North America Virus Like Particles Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Virus Like Particles Revenue Market Share by Countries in 2018
Figure 53. United States Virus Like Particles Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Canada Virus Like Particles Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Mexico Virus Like Particles Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Europe Virus Like Particles Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Virus Like Particles Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Virus Like Particles Revenue Market Share by Countries in 2019
Figure 59. Germany Virus Like Particles Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. UK Virus Like Particles Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. France Virus Like Particles Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Russia Virus Like Particles Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Italy Virus Like Particles Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Asia-Pacific Virus Like Particles Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Virus Like Particles Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Virus Like Particles Revenue Market Share by Regions 2019
Figure 67. China Virus Like Particles Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan Virus Like Particles Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Korea Virus Like Particles Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. India Virus Like Particles Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Southeast Asia Virus Like Particles Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. South America Virus Like Particles Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Virus Like Particles Sales Market Share by Countries in 2019
Figure 74. South America Virus Like Particles Revenue Market Share by Countries in 2019
Figure 75. Brazil Virus Like Particles Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Argentina Virus Like Particles Sales and Growth Rate (2015-2020) (K Pcs)
Figure 77. Middle East and Africa Virus Like Particles Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Virus Like Particles Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Virus Like Particles Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Virus Like Particles Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Virus Like Particles Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Egypt Virus Like Particles Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Turkey Virus Like Particles Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. South Africa Virus Like Particles Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. Global Virus Like Particles Sales and Growth Rate (2021-2025) (K Pcs)
Figure 86. Global Virus Like Particles Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Virus Like Particles Market Forecast (2021-2025) (K Pcs)
Figure 88. Europe Sales Virus Like Particles Market Forecast (2021-2025) (K Pcs)
Figure 89. Asia-Pacific Sales Virus Like Particles Market Forecast (2021-2025) (K Pcs)
Figure 90. South America Sales Virus Like Particles Market Forecast (2021-2025) (K Pcs)
Figure 91. Middle East & Africa Sales Virus Like Particles Market Forecast (2021-2025) (K Pcs)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
予防的B型肝炎ウイルスワクチンの世界市場（～2026年） The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer. The increasing prevalence and incidence of hepatitis B infection is the dominant factor of driving the growth…- C型肝炎ウイルス（HCV）の世界市場（～2026年） Inflammation of liver causes hepatitis. Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chro…
- C型肝炎ウイルス（HCV）抗ウイルス剤の世界市場（～2026年） Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chronic hepatitis infection. Chronic hepatit…
- C型肝炎ウイルスエンベロープタンパク質E2の世界市場（～2026年） Market Analysis and Insights: Global Hepatitis C Virus Envelope Protein E2 Market The global Hepatitis C Virus Envelope Protein E2 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Hepatitis C Virus Envelope Protein E2 S…
- A型肝炎ウイルス細胞受容体2の世界市場（～2026年） Market Analysis and Insights: Global Hepatitis A Virus Cellular Receptor 2 Market The global Hepatitis A Virus Cellular Receptor 2 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Hepatitis A Virus Cellular Receptor 2 S…